Fígado

​​​​Dr. Mario Guimarães Pessoa

CRM (SP): 54.114

Formação profissional

  • Universidade Federal da Bahia (1984).
  • Especialização em Hepatologia e Gastroenterologia.
  • Pos-doutorado em Hepatologia e Gastroeneterologia na Universidade da California, Sao Francisco 1995-1998.

Principais áreas de interesse

  • Hepatologia
  • Transplante de Fígado

Títulos, cargos e filiações

  • Clínica Médica Universidade Federal da Bahia 1985-1986.
  • Gastroenterologia Universidade de São Paulo 1986-1988 (Residência Médica).
  • Hepatologia Sociedade Brasileira de Hepatologia 1991 (Titulo de Especialista).
  • Research Methods Workshop (9 weeks) – Department of Epidemiology and Biostatistics University of California, San Francisco 1995.

Publicações

  • Pessôa MG, Wright TL. Hepatitis G: A virus in search of a disease. In: Hepatology; 1996;24(2):461-463.
  • Pessôa MG. Infection with Hepatitis GB Virus C in patients on maintenance hemodialysis. Adv Gastroenterol Hepatol Clin Nutr 1997;1:263-6.
  • Pessôa MG, Terrault NA, Ferrell L, Kim J, et al. Hepatitis G virus in patients with cryptogenic liver disease undergoing liver transplantation. Hepatology. 1997; 25:1266-70.
  • Pessôa MG, Wright TL. Hepatitis C infection in transplantation. Clinics in Liver Disease. 1997; 1(3):663-690.
  • Pessôa MG, Wright TL. Hepatitis G virus: What is the next step? Liver Transplantation and Surgery. 1997; 3(6): 677-679.
  • Pessôa MG, Terrault NA, Detmer J, Kolberg J, et al. Quantitation of hepatitis G virus and hepatitis C virus in Liver: Evidence that HGV is not a hepatotropic virus. Hepatology 1998;27(3):877-80.
  • Hassoba H, Pessôa MG, Terrault NA, Lewis N, et al. Anti-envelope antibodies are protective against GBV-C reinfection: Evidence from the liver transplant model. J Med Virol. 1998.
  • Pessôa MG, Terrault NA, Ferrell L, Detmer J, et al. Hepatitis following liver transplantation: the role of known and unknown viruses. Liver Transplantation and Surgery. 1998; 4(6), Nov:461-468.
  • Pessôa MG, Wright TL. Current treatment of chronic Hepatitis B virus disease. American Journal of Gastroenterology. 1998.
  • Pessôa MG, Wright TL. Update on clinical trials in the treatment of hepatitis B. J Gastroenterol Hepatol. 1999; May 14 Suppl:S6-11.
  • Hassoba H, Bzowej N, Grant R, Pessôa MG, et al. Evolution of viral quasispecies in Interferon treated patients with chronic hepatitis C virus infection. J of Hepatology. 1999; 31 (4):618-627.13. Sette Jr. H, Lopes E, Pessôa MG, Barros M. Transplante hepático nas hepatites crônicas virais. Gastroenterologia Clínica. Castro, LP (ed.). 1999.
  • 14. Pessôa MG, Bzowej N, Berenguer M, et al. Evolution of hepatitis C virus quasispecies in patients with severe cholestatic hepatitis after liver transplantation. Hepatology. 1999; 30 (6):1513-1520.
  • 15. Sette Jr. H, Barros M, Cury R, Pessôa MG. Liver transplant: organ procurement, allocation, and distribution policies in Brazil. Review article. GED. 2000;19(1):28-36.
  • 16. Pessôa MG. Non-A through –E Posttransplantation Hepatitis: The role of Other Viruses. Therapy in Hepatology. Arroyo,V, Bbosch J, Bruix J, Ginès P, Navasa M & Rodés J. (eds.). Barcelona, 2001.
  • 17. Pessôa MG. O Papel dos Novos Vírus nas Hepatites Não-A a E. Participação Científica Brasileira. Congresses Update. 2001.
  • 18. Pessôa MG, Fox R & Wright TL. Extrahepatic Manifestations of Hepatitis. In: Schiff’s Diseases of the Liver. Schiff E. (ed.), Lippincott Williams & Wilkins; 9th edition, 2002.
  • 19. Pessôa MG & Sette, H. Cirrose Criptogênica. Berenguer, J. (ed.). Gastroenterologia y Hepatologia. 3ª Ed. Valencia, Espanha, 2002.
  • 20. Pessôa MG. Hepatite colestática associada ao vírus da Hepatite C pós-transplante hepático: estudo virológico, histopatológico e imuno-histoquímico. Tese de Doutorado. Universidade de São Paulo, 2003.
  • 21. Pessôa MG. Conduta terapêutica na cirrose descompensada pelo vírus B, no pré- e pós-transplante. Consenso sobre condutas na Hepatite B e na Hepatite C da Sociedade Brasileira de Hepatologia. GED 2005.
  • 22. Schiff E, Pessôa MG, Tran T & Terrault N. The Bridge of Experience: Applying Lessons Learned from HCV to the HBV-Infected Patient. Independent CME activity supported by an educational grant from Bristol-Myers Squibb Company. 2005.
  • 23. Brandão C, Pessôa MG, Cheinquer H, et al. Efficacy study comparing the combination of pegylated-interferon alpha-2a and ribavirin, 24 versus 48 weeks in the treatment of patients with chronic HCV infection with genotype 1. J of Viral Hepatitis, 2006.
  • 24. Parise E, Cheinquer H, Pessôa MG et al. Peginterferon alfa-2a plus ribavirin in retreatment of chronica hepatitis C patients, nonresponders and relapsers to previous conventional interferon plus ribavirin therapy. Braz. J. Infetious Diseases. 2006.
  • 25. Lissen E, Clumeck N, Sola R, Mendes-Correa M, Montaner J, Nelson M, DePamphilis J, Pessôa MG, et al. Histological response in patients with HIV-HCV co-infection: results of the AIDS Pegasys Ribavirin International Co-infection Trial (APRICOT). AIDS. 2006; 20(17): 2175-2181.
  • 26. Gonzalez, MP & Pessôa MG. HIV/HCV coinfection: refining or redefining concepts? (Editorial). Liver International. Dec, 2006 27. Daruich J, Gadano A, Fainboin H, Pessôa MG, Cheinquer H. Guia latinoamericana de tratamiento de la Hepatitis crônica B. Acta Gastroenterológica Latinoamericana. 2007:37(3); 168-177.
  • 28. Bittencourt PL, Silva RCMS, Pessôa MG, Marroni CA et al. [National survey about management and treatment options of hepatitis C recurrence after liver transplantation]. Arquivos de Gastroenterologia. 2007; 44(1):78-84.
  • 29. Castelo A, Pessôa MG, Barreto TC, Alves MR, Araújo DV. Custo da Hepatite Crônica B no Sistema Único de Saúde. Revista Médica Brasileira. 2007.
  • 30. Rodriguez-Torres M, Govindarajan S, Sola R, Clumeck N, Lissen N, Pessôa MG, Buggisch P, Main J, DePamphilis J, Dieterich D. Liver Steatosis, Lipids And Body Composition In The Setting of HIV-HCV Co-Infection: Findings From A Large Randomised Trial. J Hepatology. 2008 – Aceito.
  • 31. Pessôa MG, Alves VAF, Wakamatsu A, et al. Post-transplant recurrent hepatitis C – Immunohistochemical detection of HCV core antigen and possible pathogenic implications. Liver International. 2008 - Aceito.

 


Você está visualizando:

Fígado

Outros conteúdos disponíveis para esta especialidade: